Stock 4530 HISAMITSU PHARMACEUTICAL CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-03 am EDT 		5-day change 1st Jan Change
3,752 JPY -0.03% Intraday chart for Hisamitsu Pharmaceutical Co., Inc. -0.08% -12.97%
Jun. 24 Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100 CI
May. 24 Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024.
CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on May 23, 2024, has closed with 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
CI
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
CI
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.
CI
Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders
PU
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024
MT
Hisamitsu Pharmaceutical : Earning Document
PU
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”
PU
Final dividend
FA
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise
MT
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
CI
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
CI
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares
PU
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.
PU
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales
MT
Hisamitsu Pharmaceutical : Earning Document
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4530 Stock
  4. News Hisamitsu Pharmaceutical Co., Inc.